Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser

European Journal of Clinical Pharmacology

Volumn 57, Issue 11, 2002, Pages 781-786

  Silkstone, V L ^a   Corlett, S A ^a   Chrystyn, H ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Relative lung bioavailability; Salbutamol; Urinary excretion

Indexed keywords

DRUG METABOLITE; SALBUTAMOL;

ADULT; ARTICLE; BREATHING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EXCRETION; HUMAN; INTERMETHOD COMPARISON; LUNG; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; NORMAL HUMAN; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; URINALYSIS; URINARY EXCRETION;

ADULT; ALBUTEROL; BIOLOGICAL AVAILABILITY; BRONCHODILATOR AGENTS; FEMALE; HUMANS; LUNG; MALE; NEBULIZERS AND VAPORIZERS;

EID: 0035709289     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-001-0382-9     Document Type: Article

References (32)

1. Emergency department treatment of severe asthma: Metered dose inhaler plus holding chamber is equivalent in effectiveness to nebuliser
2. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease
3. Efficacy of albuterol administered by nebuliser vs spacer in children with acute asthma
4. Metered dose inhalers with spacers vs nebulisers for pediatric asthma
5. Pressurised aerosol with conical spacer is an effective alternative to nebuliser in chronic stable asthma
6. Drug delivery in asthma: A comparison of spacers with a jet nebuliser
7. High-dose inhaled terbutaline in the management of chronic severe asthma: Comparison of wet nebulisation and tube spacer delivery
8. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation and multiple actuations of drug
9. Multiple actuations of salbutamol MDI into a spacer reduce the amount of drug recovered in the respirable range
10. Comparison of three techniques of inhalation on the airway response to terbutaline
11. Salbutamol aerosol delivery in man with the Rondo Spacer
12. Wastage of drug from nebulisers - A review
13. The rational use of nebulizers in clinical practice
14. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ('Ventstream')
15. Some functional aspects of air-jet nebulizers
16. Nebuliser performance: AFCM study
17. Delivery of albuterol and ipratrapium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition
18. An investigation of in-vitro/in-vivo correlations for salbutamol nebulised by eight systems
19. Relative bioavailability of salbutamol to the lungs following inhalation
20. Pulmonary deposition of inhaled terbutaline: Comparison of scanning gamma camera and urinary excretion methods
21. Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged
22. Why nebulise for more than 5 minutes?
23. Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet
24. Therapeutic equivalence of inhaled salbutamol
25. Systemic bioavailability and potency of high-dose inhaled corticosteroids: A comparison of four inhaler devices and three drugs in healthy adults
26. Predicting regional lung dosages of a nebulized suspension: Pulmicort (budesonide)
27. Relative bioavailability of salbutamol to the lungs following inhalation using metered dose inhaler methods and spacer devices
28. The effect of delay, multiple actuations and spacer charge on the in-vitro delivery of budesonide from the Nebuhaler
29. Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children
30. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as a nebuliser solution
31. Pharmacokinetics of intravenous and oral salbutamol and its sulphate comjugate
32. Effects of airway calibre on lung delivery of nebulised salbutamol